JillGilbertMD

Oncology • Nashville, TN

Endocrine Cancer, Head & Neck Cancer, Hematologic Oncology

Professor of Medicine, Vanderbilt University

Join to view full profile

Dr. Gilbert is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Gilbert's full profile

Already have an account?

Office
3601 The Vanderbilt Clinic
Henry-Joyce Cancer Clinic
Nashville, TN 37232
Phone+1 615-322-3000
Is this information wrong?

Education & Training

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1998 - 2001
University of Alabama Medical CenterResidency, Internal Medicine, 1994 - 1998
University of Alabama School of MedicineClass of 1994

Certifications & Licensure

TN State Medical License 2006 - 2026
LA State Medical License 1995 - 2024
AL State Medical License 1995 - 2020
MD State Medical License 1998 - 2002
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer Start of enrollment: 2004 Aug 01
Terminated
Phase 3
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors Start of enrollment: 2009 Mar 16
Completed
Phase 2
Everolimus Versus Placebo in Head and Neck Cancer Start of enrollment: 2010 Apr 01
Terminated
Phase 2
Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer Start of enrollment: 2010 Sep 09
Completed
Phase 1, Phase 2
Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2012 Feb 01
Completed
Phase 2
A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2012 Nov 12
Terminated
Phase 1, Phase 2
Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141) Start of enrollment: 2014 May 29
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

6 citations
Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers.
Xiuning Le, Christina Baik, Jessica Bauman, Jill Gilbert, Marcia S Brose, Juneko E Grilley-Olson, Tejas Patil, Ray McDermott, Luis E Raez, Jennifer M Johnson, Lin Shen...> ;The Oncologist. 2022 May 10
1 citations
Mature follow up of induction chemotherapy with carboplatin, nab-paclitaxel, cetuximab in head and neck squamous cell carcinoma.
Siddharth Sheth, Jill Gilbert, Allison Mary Deal, Bhishamjit Chera, Barbara Murphy, Justin Woods, Kelsey Miller, Mark Weissler, Trevor Hackman, Jay Justin Liao, Juneko...> ;Oral Oncology. 2022 Apr 1
4 citations
Safety and Efficacy of Avelumab in Small Bowel Adenocarcinoma.
Dana B Cardin, Jill Gilbert, Jennifer G Whisenant, Gregory D Ayers, Florencia Jalikis, Kimberly B Dahlman, Jamye F O'Neal, Frank Revetta, Chanjuan Shi, Jordan Berlin> ;Clinical Colorectal Cancer. 2022 Sep 1
4 citations
Forming the Hematology-Oncology Collaborative Videoconferencing (CO-VID) Learning Initiative: Experiential Lessons Learned From a Novel Trainee-Led Multidisciplinary V...
Richard L. Martin, Michael J. Grant, Stephen Kimani, Shonali Midha, Jori May, Rushad Patell, Emily F. Collier, David Furfaro, Charles Bodine, Leo Reap, Nikesh N. Shah,...> ;JCO Oncology Practice. 2021 Jul 9
13 citations
Refinement and Validation of the Head and Neck Lymphedema and Fibrosis Symptom Inventory
Jie Deng, Mary S. Dietrich, Kenneth J. Niermann, Robert J. Sinard, Anthony J. Cmelak, Sheila H. Ridner, Jill Gilbert, Barbara A. Murphy> ;International Journal of Radiation Oncology, Biology, Physics. 2021 Mar 1
16 citations
Preventive use of gabapentin to decrease pain and systemic symptoms in patients with head and neck cancer undergoing chemoradiation.
Derek K. Smith, Anthony J. Cmelak, Ken Niermann, Michael K. Ghiam, Diane Lou, Jill Gilbert, Michael K. Gibson, Deborah K. Hawkins, Barbara A. Murphy> ;Head & Neck. 2020 Aug 7
573 citations
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
David G. Pfister, Sharon A. Spencer, David J. Adelstein, Douglas Adkins, Yoshimi Anzai, David M. Brizel, Justine Yang Bruce, Paul M. Busse, Jimmy J. Caudell, Anthony J...> ;Journal of the National Comprehensive Cancer Network. 2020 Jul 1
12 citations
Clinical Activity and Safety of Atezolizumab in a Phase 1 Study of Patients With Relapsed/Refractory Small-Cell Lung Cancer
Anne C. Chiang, Lecia V. Sequist, Jill Gilbert, Paul Conkling, D. S. Thompson, J. Paul Marcoux, Scott N. Gettinger, Marcin Kowanetz, Luciana Molinero, Carol O'Hear, Ma...> ;Clinical Lung Cancer. 2020 May 12
56 citations
Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer.
Athanassios Argiris, Shuli Li, Panayiotis Savvides, James Ohr, Jill Gilbert, Marshall A. Levine, Arnab Chakravarti, Missak Haigentz, Nabil F. Saba, Chukwuemeka Ikpeazu...> ;Journal of Clinical Oncology. 2019 Oct 16
112 citations
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer
Janice M. Mehnert, Andrea Varga, Marcia S. Brose, Rahul Aggarwal, Chia-Chi Lin, Amy Prawira, Filippo de Braud, Kenji Tamura, Toshihiko Doi, Sarina Anne Piha-Paul, Jill...> ;BMC Cancer. 2019 Mar 4
7 citations
Genomic landscape of a metastatic malignant proliferating tricholemmal tumor and its response to PI3K inhibition.
Jean-Nicolas Gallant, Andrew Sewell, Karinna Almodovar, Qingguo Wang, Kimberly B. Dahlman, Richard G. Abramson, Meghan E. Kapp, Brandee T. Brown, Kelli L. Boyd, Jill G...> ;NPJ Precision Oncology. 2019 Feb 15
206 citations
Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1-Low/Negative Recurrent or Metastatic HNSCC: The Phase 2 CONDOR Randomized Clinica...
Lillian L. Siu, Caroline Even, Ricard Mesia, Éva Remenár, Amaury Daste, Jean Pierre Delord, Jürgen Krauss, Nabil F. Saba, Lisle Nabell, Neal Ready, Irene Brana, Nuria ...> ;JAMA Oncology. 2019 Feb 1
162 citations
Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 express...
Dan P. Zandberg, Alain Algazi, Antonio Jimeno, J. Good, Jérôme Fayette, Nathaniel Bouganim, Neal Ready, Paul Clement, Caroline Even, Raymond Woo-Jun Jang, Stuart J. Wo...> ;European Journal of Cancer. 2019 Jan 1
123 citations
Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 Study
Roger B. Cohen, Jean Pierre Delord, Toshihiko Doi, Sarina Anne Piha-Paul, Stephen V. Liu, Jill Gilbert, Alain Algazi, Silvia Damian, Ruey-Long Hong, Christophe Le Tour...> ;American Journal of Clinical Oncology. 2018 Nov 1
17 citations
Induction chemotherapy with carboplatin, nab-paclitaxel and cetuximab for at least N2b nodal status or surgically unresectable squamous cell carcinoma of the head and ...
Jared Weiss, Jill Gilbert, Allison M. Deal, Mark C. Weissler, Chris Hilliard, Bhishamjit S. Chera, Barbara A. Murphy, Trevor Hackman, J.J. Liao, Juneko E. Grilley Olso...> ;Oral Oncology. 2018 Sep 1
9 citations
Ectopic, retroperitoneal adrenocortical carcinoma in the setting of Lynch syndrome.
Jesse P. Wright, Kathleen W. Montgomery, Joshua Tierney, Jill Gilbert, Carmen C. Solorzano, Kamran Idrees> ;Familial Cancer. 2018 Jul 1
20 citations
A Randomized Feasibility Trial to Evaluate Use of the Jaw Dynasplint to Prevent Trismus in Patients With Head and Neck Cancer Receiving Primary or Adjuvant Radiation-B...
Lauren Azure Zatarain, Derek K. Smith, Jie Deng, Jill Gilbert, Mary S. Dietrich, Kenneth J. Niermann, Sheila H. Ridner, Barbara A. Murphy> ;Integrative Cancer Therapies. 2018 Jun 28
391 citations
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018
A. Dimitrios Colevas, Sue S. Yom, David G. Pfister, Sharon A. Spencer, David J. Adelstein, Douglas Adkins, David M. Brizel, Barbara Burtness, Paul M. Busse, Jimmy J. C...> ;Journal of the National Comprehensive Cancer Network. 2018 May 1
32 citations
Management of treatment-related toxicities in advanced medullary thyroid cancer.
Marcia S. Brose, Keith C. Bible, Laura Q.M. Chow, Jill Gilbert, Carolyn Grande, Francis P. Worden, Robert I. Haddad> ;Cancer Treatment Reviews. 2018 May 1
9 citations
Intracardiac Metastases Detected by 18F-FSPG PET/CT
Meaghan A. Magarik, Ronald C. Walker, Jill Gilbert, H. Charles Manning, Pierre P. Massion> ;Clinical Nuclear Medicine. 2018 Jan 1
3 citations
Immunotherapy: Who Is Eligible?
Daniel Wang, Jill Gilbert, Young J. Kim> ;Otolaryngologic Clinics of North America. 2017 Aug 1
264 citations
NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017
David J. Adelstein, Maura L. Gillison, David G. Pfister, Sharon A. Spencer, Douglas Adkins, David M. Brizel, Barbara Burtness, Paul M. Busse, Jimmy J. Caudell, Anthony...> ;Journal of the National Comprehensive Cancer Network. 2017 Jun 1
437 citations
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study.
Joshua Bauml, Tanguy Y. Seiwert, David G. Pfister, Francis P. Worden, Stephen V. Liu, Jill Gilbert, Nabil F. Saba, Jared Weiss, Lori J. Wirth, Ammar Sukari, Hyunseok K...> ;Journal of Clinical Oncology. 2017 Mar 22
20 citations
Assessment of musculoskeletal impairment in head and neck cancer patients
Michael K. Ghiam, Kyle Mannion, Mary S. Dietrich, Kristen L. Stevens, Jill Gilbert, Barbara A. Murphy> ;Supportive Care in Cancer. 2017 Feb 13
301 citations
E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcin...
Shanthi Marur, Shuli Li, Anthony J. Cmelak, Maura L. Gillison, Weiqiang Zhao, Robert L. Ferris, William H. Westra, Jill Gilbert, Julie E. Bauman, Lynne I. Wagner, Davi...> ;Journal of Clinical Oncology. 2017 Feb 10
Join now to see all

Press Mentions

Genomic Analysis Reveals Many Animal Species May Be Vulnerable to SARS-CoV-2 InfectionAugust 21st, 2020
Endowed Fellowships Help Create Personal ConnectionsMay 12th, 2016